Member Info for mavs

Just noticed our US Distributor Bruker has released an RNS,. it is holding it's Annual Meeting to Stockholders on Thursday 21st ,10am eastern time,maybe relevant to our news release due this week.

Thanks for posting this Woodaldo, great research yet again,Can I push the BOOM button now?

Sure its not Sam -12345

@jwilits The Vox markets app seems ok,the companys in your watch list do seem quite accurate.

MrSpeculator,Congrats on your trades on here.Ive been here since 80p and still hold as well as having a smaller position in Avct also.The fact that Nova has this relationship with the 2 heavy weights does give me a lot of confidence here,as we have already seen progress with the new dpcr test for example and even more innovation in the future as they evolve.Contracts are for sure being discussed and new opportunities will continue to arise ,there is enough room for everyone to this world wide solution,the goodnews is we months ahead of the game here.imo

Dr A Smith Ceo of Avacta commented today in their Rns :A consensus view is building around the world that hundreds of millions of COVID-19 tests are going to be required per month for a long period, and that the disease will be endemic after the initial pandemic has passed, meaning that testing for COVID-19 is going to be needed for many years.

Not open for trading tomorrow,maybe an afternoon push.

Precisely.

In an interview with Thermo Fisher ceo Marc Casper on Cnbc this evening Mr Casper referred their test as the Gold standard when questioned on it’s accuracy. Sound familiar?tick tock.

Agree,bounced off 16.50 on bid last week.

If you look on ncyt website they require 4 quality control technicians for a fixed 6 month contract, looks like ygen will be busy until a least near year End with this venture.

Astra Zeneca mentioned working in a consortium on antibody test , is that us also?

Another 4K for the Isa.

I know we are not an antibody test but maybe of interest:Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity
21st April 2020, 13:30

Bio-Rad Begins Shipping SARS-COV-2 (COVID-19) Antibody Test That Offers More Than 99 Percent Specificity and 98 Percent Sensitivity
21st April 2020, 13:30

I think Trumps referring to Ncyt new dPCR test due to roll out early May.

1m sell just gone through at £5.10 @3.52

NIPT approval in first quarter, sales should fly once approved in the next 10 weeks max.

On the move today getting near year highs with update due soon.

The rns alerts mentioned by silver was vox markets.